4
Changes in Ownership
PLIANT THERAPEUTICS, INC. Filed Acc 0001140361-23-002786
President and CEO sold 60,000 shares at an average $33.12 ($1,987,473)
- President and CEO acquired 45,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Coulie Bernard President and CEO | 2023-01-23 | Option exercise | +15,000 | $2.08 | $31,200 | 108,812 | D: show line 1 in the form |
| Coulie Bernard President and CEO | 2023-01-23 | Sale | −10,150 | $33.71 | $342,163 | 98,662 | D: show line 2 in the form |
| Coulie Bernard President and CEO | 2023-01-23 | Sale | −4,850 | $34.93 | $169,405 | 93,812 | D: show line 3 in the form |
| Coulie Bernard President and CEO | 2023-01-23 | Sale | −15,000 | $35.00 | $525,000 | 434,317 | I: show line 4 in the form |
| Coulie Bernard President and CEO | 2023-01-24 | Option exercise | +15,000 | $2.08 | $31,200 | 108,812 | D: show line 5 in the form |
| Coulie Bernard President and CEO | 2023-01-24 | Sale | −15,000 | $30.89 | $463,389 | 93,812 | D: show line 6 in the form |
| Coulie Bernard President and CEO | 2023-01-25 | Option exercise | +15,000 | $2.08 | $31,200 | 108,812 | D: show line 7 in the form |
| Coulie Bernard President and CEO | 2023-01-25 | Sale | −13,304 | $32.40 | $431,058 | 95,508 | D: show line 8 in the form |
| Coulie Bernard President and CEO | 2023-01-25 | Sale | −1,696 | $33.29 | $56,459 | 93,812 | D: show line 9 in the form |
| Open-market sales · 60,000 sh · avg $33.12 · $1,987,473 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Coulie Bernard President and CEO | 2023-01-23 | Option exercise · Stock Option (right to buy) | −15,000 | 232,380 | D: show line 10 in the form | ||
| Coulie Bernard President and CEO | 2023-01-24 | Option exercise · Stock Option (right to buy) | −15,000 | 217,380 | D: show line 11 in the form | ||
| Coulie Bernard President and CEO | 2023-01-25 | Option exercise · Stock Option (right to buy) | −15,000 | 202,380 | D: show line 12 in the form |
Loading xslF345X03/form4.xml…